Latest news and press releases about TransMedics Group, Inc. (TMDX): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs.
Price
| Price | $82.73 |
| Market Cap | $2.9B |
| Exchange | NASDAQ |
| Country | US |
Related companies: AKRO · BRKR · GKOS · HNGE · IMVT · INDV · KYMR
Explore sector: Healthcare · Medical - Devices
More sections of TMDX: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks